anti-EGFRvIII CAR T cell therapy / Suzhou Maximum Bio-tech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
anti-EGFRvIII CAR T cell therapy / Suzhou Maximum Bio-tech
ChiCTR1900020829: An open-label, single-center clinical study for infusion of anti-EGFRvIII CAR-T cells for patients with advanced Glioma

Not yet recruiting
1
12
 
EGFRvIII CAR-T cell therapy
The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University, Suzhou Maximum Bio-tech Co., Ltd.
brain glioma
 
 

Download Options